$ENS

Newark’s Ultralife to be sold to Pennsylvania company

Ultralife Corporation (ULBI) is being acquired by EnerSys (ENS) in a $320M cash deal. Ultralife shareholders will receive $16 per share. The merger aims to combine power solutions and expand defense market capabilities, according to both companies.

Original reporting
Published Oct 28, 2026, 2:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 5:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ENS
Neutral
medium confidence
Mentioned
$ENS · $ULBI
Relevance
9/10
AlphAI data visualization · based on fltimes.com
Decision brief

The 30-second read

$ENSNeutralHigh
01

Why it matters

The deal creates a larger platform for defense power solutions, potentially reshaping market share among battery manufacturers serving military applications.

02

Market read

A $320 million all‑cash acquisition that expands EnerSys’s defense portfolio and provides a cash premium to Ultralife shareholders.

03

What to watch

Regulatory approvals for defense‑related technology transfers and integration of Ultralife’s multi‑chemistry capabilities may delay value realization.

Relevance 9/10Novelty 9/10Timing: announcement day

Background

The article reports the first public disclosure of the Ultralife‑EnerSys merger, detailing transaction value and strategic rationale.

Company-level read

Ticker impact

$ENSNeutralMedium confidence
Context

EnerSys disclosed it will acquire Ultralife Corp for $320 million, expanding its defense‑power portfolio.

Expected impact

potential slight pressure as the market evaluates financing and integration risk

Evidence & confidence

Acquisition adds growth opportunities but the cash cost could temper short‑term sentiment.

Market effects

Strengthens the defense‑power and energy‑storage segment, potentially boosting peers in the industrial battery space.

Both companies are US‑based, so the deal primarily affects US industrial and defense markets.

Adds to consolidation trends in the global energy‑storage industry, signaling continued demand from defense customers.

Counterpoint

EnerSys’s cash outlay could strain balance sheet liquidity, risking a short‑term pullback despite strategic fit.

Key entities

  • Ultralife Corp

    Battery manufacturer being acquired.

  • EnerSys

    Stored‑energy manufacturer acquiring Ultralife.

Related articles

$ULBIMed

Freedom: Ultralife upside after acquisition announcement is almost exhausted

Ultralife (ULBI) shares rose 145.4% to $15.61 after EnerSys (ENS) agreed to acquire it for $16 per share, a 166% premium. The deal, valued at $320M, is expected to close in Q1 2027. Analyst Vladimir Chernov sees limited upside for ULBI, with shares likely staying in the $15.5–16 range until the deal closes. ENS expects cost savings and EPS growth post-acquisition.

$ENSMedAI 8/10

EnerSys to acquire Ultralife for $320 million

EnerSys (ENS) to acquire Ultralife (ULBI) for $320M, or $16 per share. The deal, expected to close in Q1 2027, aims to expand EnerSys's defense power platform. Ultralife generated $191M revenue in fiscal 2025. EnerSys expects $15-20M in annual cost synergies within 18 months.

$ENSHighAI 9/10

EnerSys Pays 166% Premium for Ultralife to Expand Defense Batteries

EnerSys (ENS) will acquire Ultralife (ULBI) for $16.00 per share, a 166% premium, with a $320M enterprise value. The deal expands EnerSys' defense business, adding U.S. manufacturing for compliant batteries. EnerSys expects $15M-$20M in annual cost synergies and EPS growth within 18 months. Ultralife's 2025 revenue was $191M. The deal, funded by cash, requires majority shareholder approval and regulatory clearance, expected to close in Q1 2027.

$ULBIHigh

Ultralife to Be Acquired by EnerSys for $16 Per Share in Cash

Ultralife (ULBI) agreed to be acquired by EnerSys for $16 per share in cash. The deal requires a tender offer and merger, with no financing condition. Stockholders owning 40.3% of shares support the deal but do not meet the minimum tender condition alone. The merger agreement includes repayment of Ultralife's outstanding credit agreement at closing.